Bristol-Myers Squibb, Toast And A Major REIT Stock: CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Bristol-Myers Squibb Company BMY, which announced $4 billion aggregate accelerated share repurchase agreements.

Bristol Myers Squibb recently said that its second-quarter revenues of $11.23 billion declined 6% Y/Y, or 5% when adjusted for foreign exchange, due to lower sales of Revlimid, partially offset by in-line products and our new product portfolio. Analysts estimated sales of $11.81 billion.

Jenny Harrington of Gilman Hill Asset Management named NNN REIT, Inc. NNN, which announced earnings last week. The company has a 5.6% dividend yield.

NNN REIT recently priced its public offering of $500 million of 5.600% senior unsecured notes due 2033.

Analysts have a consensus Buy rating on NNN REIT, according to Benzinga's analyst ratings data.

Josh Brown of Ritholtz Wealth Management said Toast, Inc. TOST had a bunch of price-target hikes on the Street following the earnings release. "I am staying long," he added.

Toast reported mixed second-quarter financial results and issued guidance above estimates.

Don’t forget to check out our premarket coverage here

Price Action: Toast shares fell 1.8% to settle at $22.77, while NNN REIT shares slipped 0.1% to close at $39.96 on Thursday. Bristol-Myers Squibb shares gained 1.1% to $61.29 on Thursday.

Check This Out: Fear & Greed Index Remains In 'Greed' Zone Following Inflation Data

Photo: Shutterstock